跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LIPOCOMB 20 MG/10 MG CAPSULAS DURAS
Approved
STANDARD
LIPOCOMB 20 MG/10 MG CAPSULAS DURAS
Egis Pharmaceuticals Plc.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 26, 2021
Approval ID
76752de9cc3d88b5
Company
Egis Pharmaceuticals Plc.
Type
Standard
Approval Details
Approval Id
76752de9cc3d88b5
Drug Cima Aemps Name
LIPOCOMB 20 MG/10 MG CAPSULAS DURAS
Register Number
22083IP1
Holder Company Name
Egis Pharmaceuticals Plc.
Marketing Company Name
Difarmed S.L.U.
Authorization Date
2021-03-26
Dosage Form
CÁPSULA DURA
Dose
20 mg/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Egis Pharmaceuticals Plc.
Active Ingredients
ROSUVASTATINA
20 mg
EZETIMIBA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 26, 2021
Approval ID
76752de9cc3d88b5
Type
Standard
Back to CIMA-AEMPS Approvals
LIPOCOMB 20 MG/10 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details